moisturizing and nourishing cream

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• For gels and serums, the reference gives 3–8%.
• For creams, the recorded level is 2–5% as a formulation guide.
• The stated reference for rinse-off is 2–4% as a formulation guide.

The guide places Glycerin in the water phase and calls for no melt step.

4. Regulatory sources & global compliance

• Use CosIng's information on Glycerin as a reference, then verify the specific grade and intended use under market rules.
• Regulation (EC) No 1223/2009 sets the requirement for a safety assessment covering the complete formulation with Glycerin as part of the finished cosmetic's safety documentation.
• Review the documentation for the actual Glycerin grade and the filing requirements for the target market.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; it should not be read as a drug authorization or OTC listing and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; review airless or pump options if oxidation presents a concern; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The formulation note describes Glycerin as part of a cosmetic direction focused on humectant function.

• The formulation note does not demonstrate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The formulation record for Glycerin cannot establish whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• For gel-creams, the recorded level is 2–6% for the formula.
• The guide range for dry oils is 10–30%.
• The stated reference for balms is 5–15% as a formulation guide.

Incorporate Squalane in the oil phase without a separate high-shear wax step.

4. Regulatory sources & global compliance

• CosIng may identify Squalane as an ingredient, but its entry does not approve a material grade or finished formula.
• Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Squalane for the complete formula intended for sale.
• Confirm the actual Squalane grade from supplier documentation and check requirements where the product will be sold.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; no drug approval or OTC status is conferred by this entry with patch response and finished-product stability still to be verified.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; evaluate packaging against the formula's susceptibility to oxidation; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• The listed information does not establish therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The information about Squalane does not confirm skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

For creams, balms, and hair creams, shea butter supplies the triglyceride-butter cushion role; unrefined color and aroma are not presumed.

3. Typical use levels (formulation guide)

• The formulation record indicates 2–8% for creams in this reference.
• 10–25% is listed for balms and butters as a formulation guide.

Melt into the oil phase and continue shear through cooling to help keep Butyrospermum Parkii Butter from becoming grainy.

4. Regulatory sources & global compliance

• An entry for Butyrospermum Parkii Butter in CosIng is not authorization for a material grade or completed cosmetic; review local requirements.
• EU market placement under Regulation (EC) No 1223/2009 requires a safety review of the finished cosmetic in which Butyrospermum Parkii Butter is used for the product in its final form.
• Use current supplier documentation for the purchased Butyrospermum Parkii Butter grade and verify applicable destination-market filings.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; it does not establish drug approval or OTC-monograph status with patch response and finished-product stability still to be verified.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; match the pack choice to the system's oxidation risk; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The formulation note describes Butyrospermum Parkii Butter as part of a cosmetic direction focused on shea cushion.

• This reference is not evidence of claims of drug action or cure, or a product certification outside the supporting records.
• This cosmetic entry naming Butyrospermum Parkii Butter does not establish whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.